Skip to main content
Clinical Trials/JPRN-UMIN000036143
JPRN-UMIN000036143
Completed
N/A

Comparisons of changes in circulating vascular endothelial growth factor-A and renal vascular parameters after intravitreal ranibizumab or aflibercept for retinal vascular disease - Comparisons of changes in circulating vascular endothelial growth factor-A and renal vascular parameters after intravitreal ranibizumab or aflibercept for retinal vascular disease

Tosei General Hospital0 sites40 target enrollmentMarch 10, 2019

Overview

Phase
N/A
Intervention
Not specified
Conditions
age-related macular degeneration, diabetic macular edema, macular edema secondary to retinal vein occlusion
Sponsor
Tosei General Hospital
Enrollment
40
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 10, 2019
End Date
July 3, 2017
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)Patients who had received systemic anti\-VEGF therapy for malignancy. 2\)Patients who were currently on dialysis. 3\)Patients who had undergone vitrectomy in the treated eye. 4\)Patients who had severely high albuminuria (A3 category, KDIGO 2012\).

Outcomes

Primary Outcomes

Not specified

Similar Trials